A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy

Nucleic Acids Research

Volumn 42, Issue 10, 2014, Pages 6106-6127

  Liu, Chao ^a   Srihari, Sriganesh ^a   Cao, Kim Anh Lê ^a   Chenevix Trench, Georgia ^b   Simpson, Peter T ^a   Ragan, Mark A ^a   Khanna, Kum Kum ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

APOPTOSIS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER THERAPY; CHROMATIN; DNA DEGRADATION; DNA END JOINING REPAIR; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; DOWN REGULATION; EPIGENETICS; GENE MUTATION; HUMAN; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; MOLECULARLY TARGETED THERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECOMBINATION REPAIR; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UBIQUITINATION;

BREAST NEOPLASMS; CARCINOGENESIS; DNA BREAKS, DOUBLE-STRANDED; DNA END-JOINING REPAIR; FEMALE; HUMANS; RECOMBINATIONAL DNA REPAIR;

EID: 84903142681     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku284     Document Type: Review

References (261)

1. Khanna, K.K. and Jackson, S.P. (2001) DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet., 27, 247-254.
2. Rich, T., Allen, R.L. and Wyllie, A.H. (2000) Defying death after DNA damage. Nature, 407, 777-783.
3. Stephens, P.J., McBride, D.J., Lin, M.-L., Varela, I., Pleasance, E.D., Simpson, J.T., Stebbings, L.A., Leroy, C., Edkins, S., Mudie, L.J. et al. (2009) Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature, 462, 1005-1010.
4. Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A. and Kinzler, K.W. (2013) Cancer genome landscapes. Science, 339, 1546-1558.
5. Fojo, T. (2001) Cancer, DNA repair mechanisms, and resistance to chemotherapy. J. Natl. Cancer Inst., 93, 1434-1436.
6. Lord, C.J. and Ashworth, A. (2012) The DNA damage response and cancer therapy. Nature, 481, 287-294.
7. Ciccia, A. and Elledge, S.J. (2010) The DNA damage response: making it safe to play with knives. Mol. Cell, 40, 179-204.
8. Surova, O. and Zhivotovsky, B. (2013) Various modes of cell death induced by DNA damage. Oncogene, 32, 3789-3797.
9. Shiloh, Y. and Ziv, Y. (2013) The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat. Rev. Mol. Cell Biol., 14, 197-210.
10. Abraham, R.T. (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev., 15, 2177-2196.
11. Matsuoka, S., Ballif, B.A., Smogorzewska, A., McDonald, E.R., Hurov, K.E., Luo, J., Bakalarski, C.E., Zhao, Z., Solimini, N., Lerenthal, Y. et al. (2007) ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science, 316, 1160-1166.
12. Bensimon, A., Schmidt, A., Ziv, Y., Elkon, R., Wang, S.-Y., Chen, D.J., Aebersold, R. and Shiloh, Y. (2010) ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage. Sci. Signal, 3, rs3.
13. Bennetzen, M.V., Larsen, D.H., Bunkenborg, J., Bartek, J., Lukas, J. and Andersen, J.S. (2010) Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response. Mol. Cell. Proteomics, 9, 1314-1323.
14. Smith, J., Tho, L.M., Xu, N. and Gillespie, D.A. (2010) The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv. Cancer Res., 108, 73-112.
15. Kuerbitz, S.J., Plunkett, B.S., Walsh, W.V. and Kastan, M.B. (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. U.S.A., 89, 7491-7495.
16. Macleod, K.F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B. and Jacks, T. (1995) p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev., 9, 935-944.
17. Manke, I.A., Nguyen, A., Lim, D., Stewart, M.Q., Elia, A.E.H. and Yaffe, M.B. (2005) MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol. Cell, 17, 37-48.
18. Warmerdam, D.O., Brinkman, E.K., Marteijn, J.A., Medema, R.H., Kanaar, R. and Smits, V.A.J. (2013) UV-induced G2 checkpoint depends on p38 MAPK and minimal activation of ATR-Chk1 pathway. J. Cell Sci., 126, 1923-1930.
19. Wang, X., Zeng, L., Wang, J., Chau, J.F.L., Lai, K.P., Jia, D., Poonepalli, A., Hande, M.P., Liu, H., He, G. et al. (2011) A positive role for c-Abl in Atm and Atr activation in DNA damage response. Cell Death Differ., 18, 5-15.
20. Kaidi, A. and Jackson, S.P. (2013) KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling. Nature, 498, 70-74.
21. Curtin, N.J. (2012) DNA repair dysregulation from cancer driver to therapeutic target. Nat. Rev. Cancer, 12, 801-817.
22. Liu, P., Carvalho, C.M.B., Hastings, P.J. and Lupski, J.R. (2012) Mechanisms for recurrent and complex human genomic rearrangements. Curr. Opin. Genet. Dev., 22, 211-220.
23. Petermann, E. and Helleday, T. (2010) Pathways of mammalian replication fork restart. Nat. Rev. Mol. Cell Biol., 11, 683-687.
24. Alt, F.W., Zhang, Y., Meng, F.-L., Guo, C. and Schwer, B. (2013) Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell, 152, 417-429.
25. Price, B.D. and D'Andrea, A.D. (2013) Chromatin remodeling at DNA double-strand breaks. Cell, 152, 1344-1354.
26. Goodarzi, A.A. and Jeggo, P.A. (2012) The heterochromatic barrier to DNA double strand break repair: how to get the entry visa. Int. J. Mol. Sci., 13, 11844-11860.
27. Bao, Y. (2011) Chromatin response to DNA double-strand break damage. Epigenomics, 3, 307-321.
28. Chou, D.M., Adamson, B., Dephoure, N.E., Tan, X., Nottke, A.C., Hurov, K.E., Gygi, S.P., Colaiácovo, M.P. and Elledge, S.J. (2010) A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage. Proc. Natl. Acad. Sci. U.S.A., 107, 18475-18480.
29. Ahel, D., Horejsí, Z., Wiechens, N., Polo, S.E., Garcia-Wilson, E., Ahel, I., Flynn, H., Skehel, M., West, S.C., Jackson, S.P. et al. (2009) Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science, 325, 1240-1243.
30. Gottschalk, A.J., Timinszky, G., Kong, S.E., Jin, J., Cai, Y., Swanson, S.K., Washburn, M.P., Florens, L., Ladurner, A.G., Conaway, J.W. et al. (2009) Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler. Proc. Natl. Acad. Sci. U.S.A., 106, 13770-13774.
31. Luijsterburg, M.S., Acs, K., Ackermann, L., Wiegant, W.W., Bekker-Jensen, S., Larsen, D.H., Khanna, K.K., van Attikum, H., Mailand, N. and Dantuma, N.P. (2012) A new non-catalytic role for ubiquitin ligase RNF8 in unfolding higher-order chromatin structure. EMBO J., 31, 2511-2527.
32. Ismail, I.H., Andrin, C., McDonald, D. and Hendzel, M.J. (2010) BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair. J. Cell Biol., 191, 45-60.
33. Ginjala, V., Nacerddine, K., Kulkarni, A., Oza, J., Hill, S.J., Yao, M., Citterio, E., van Lohuizen, M. and Ganesan, S. (2011) BMI1 is recruited to DNA breaks and contributes to DNA damage-induced H2A ubiquitination and repair. Mol. Cell. Biol., 31, 1972-1982.
34. Ismail, I.H., McDonald, D., Strickfaden, H., Xu, Z. and Hendzel, M.J. (2013) A small molecule inhibitor of polycomb repressive complex 1 inhibits ubiquitin signaling at DNA double-strand breaks. J. Biol. Chem., 288, 26944-26954.
35. Xu, Y., Sun, Y., Jiang, X., Ayrapetov, M.K., Moskwa, P., Yang, S., Weinstock, D.M. and Price, B.D. (2010) The p400 ATPase regulates nucleosome stability and chromatin ubiquitination during DNA repair. J. Cell Biol., 191, 31-43.
36. Xu, Y., Ayrapetov, M.K., Xu, C., Gursoy-Yuzugullu, O., Hu, Y. and Price, B.D. (2012) Histone H2A.Z controls a critical chromatin remodeling step required for DNA double-strand break repair. Mol. Cell, 48, 723-733.
37. Sun, Y., Jiang, X. and Price, B.D. (2010) Tip60: connecting chromatin to DNA damage signaling. Cell Cycle, 9, 930-936.
38. Moyal, L., Lerenthal, Y., Gana-Weisz, M., Mass, G., So, S., Wang, S.-Y., Eppink, B., Chung, Y.M., Shalev, G., Shema, E. et al. (2011) Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Mol. Cell, 41, 529-542.
39. Hahn, M.A., Dickson, K.-A., Jackson, S., Clarkson, A., Gill, A.J. and Marsh, D.J. (2012) The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination. Hum. Mol. Genet., 21, 559-568.
40. Blank, M., Tang, Y., Yamashita, M., Burkett, S.S., Cheng, S.Y. and Zhang, Y.E. (2012) A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20. Nat. Med., 18, 227-234.
41. Lamarche, B.J., Orazio, N.I. and Weitzman, M.D. (2010) The MRN complex in double-strand break repair and telomere maintenance. FEBS Lett., 584, 3682-3695.
42. Stracker, T.H. and Petrini, J.H.J. (2011) The MRE11 complex: starting from the ends. Nat. Rev. Mol. Cell Biol., 12, 90-103.
43. Sun, Y., Jiang, X., Xu, Y., Ayrapetov, M.K., Moreau, L.A., Whetstine, J.R. and Price, B.D. (2009) Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60. Nat. Cell Biol., 11, 1376-1382.
44. Sun, Y., Jiang, X., Chen, S., Fernandes, N. and Price, B.D. (2005) A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc. Natl. Acad. Sci. U.S.A., 102, 13182-13187.
45. Bhatti, S., Kozlov, S., Farooqi, A.A., Naqi, A., Lavin, M. and Khanna, K.K. (2011) ATM protein kinase: the linchpin of cellular defenses to stress. Cell. Mol. Life Sci., 68, 2977-3006.
46. van Attikum, H. and Gasser, S.M. (2009) Crosstalk between histone modifications during the DNA damage response. Trends Cell Biol., 19, 207-217.
47. Ulrich, H.D. (2012) Ubiquitin and SUMO in DNA repair at a glance. J. Cell Sci., 125, 249-254.
48. Bologna, S. and Ferrari, S. (2013) It takes two to tango: Ubiquitin and SUMO in the DNA damage response. Front Genet., 4, 106.
49. Spycher, C., Miller, E.S., Townsend, K., Pavic, L., Morrice, N.A., Janscak, P., Stewart, G.S. and Stucki, M. (2008) Constitutive phosphorylation of MDC1 physically links the MRE11-RAD50-NBS1 complex to damaged chromatin. J. Cell Biol., 181, 227-240.
50. Chapman, J.R. and Jackson, S.P. (2008) Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage. EMBO Rep., 9, 795-801.
51. Bartocci, C. and Denchi, E.L. (2013) Put a RING on it: regulation and inhibition of RNF8 and RNF168 RING finger E3 ligases at DNA damage sites. Front Genet., 4, 128.
52. Zhao, Y, Brickner, JR, Majid, MC and N, Mosammaparast(2014). Crosstalk between ubiquitin and other post-translational modifications on chromatin during double-strand break repair. Trends Cell Biol, doi:10.1016/j.tcb.2014.01.005.
53. Polo, S.E. and Jackson, S.P. (2011) Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev., 25, 409-433.
54. Altmeyer, M. and Lukas, J. (2013) To spread or not to spread-chromatin modifications in response to DNA damage. Curr. Opin. Genet. Dev., 23, 156-165.
55. Bekker-Jensen, S., Rendtlew Danielsen, J., Fugger, K., Gromova, I., Nerstedt, A., Lukas, C., Bartek, J., Lukas, J. and Mailand, N. (2010) HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes. Nat. Cell Biol., 12, 80-86.
56. Danielsen, J.R., Povlsen, L.K., Villumsen, B.H., Streicher, W., Nilsson, J., Wikström, M., Bekker-Jensen, S. and Mailand, N. (2012) DNA damage-inducible SUMOylation of HERC2 promotes RNF8 binding via a novel SUMO-binding Zinc finger. J. Cell Biol., 197, 179-187.
57. Bunting, S.F., Callen, E., Wong, N., Chen, H.-T., Polato, F., Gunn, A., Bothmer, A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L. et al. (2010) 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell, 141, 243-254.
58. Bouwman, P., Aly, A., Escandell, J.M., Pieterse, M., Bartkova, J., van der Gulden, H., Hiddingh, S., Thanasoula, M., Kulkarni, A., Yang, Q. et al. (2010) 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat. Struct. Mol. Biol., 17, 688-695.
59. Grotsky, D.A., Gonzalez-Suarez, I., Novell, A., Neumann, M.A., Yaddanapudi, S.C., Croke, M., Martinez-Alonso, M., Redwood, A.B., Ortega-Martinez, S., Feng, Z. et al., (2013) BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells. J. Cell Biol., 200, 187-202.
60. Greenberg, R.A., Sobhian, B., Pathania, S., Cantor, S.B., Nakatani, Y. and Livingston, D.M. (2006) Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. Genes Dev., 20, 34-46.
61. Huen, M.S.Y., Sy, S.M.H. and Chen, J. (2010) BRCA1 and its toolbox for the maintenance of genome integrity. Nat. Rev. Mol. Cell Biol., 11, 138-148.
62. Harris, J.L. and Khanna, K.K. (2011) BRCA1 A-complex fine tunes repair functions of BRCA1. Aging (Albany N.Y.), 3, 461-463.
63. Sobhian, B., Shao, G., Lilli, D.R., Culhane, A.C., Moreau, L.A., Xia, B., Livingston, D.M. and Greenberg, R.A. (2007) RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science, 316, 1198-1202.
64. Wang, B., Matsuoka, S., Ballif, B.A., Zhang, D., Smogorzewska, A., Gygi, S.P. and Elledge, S.J. (2007) Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science, 316, 1194-1198.
65. Kim, H., Chen, J. and Yu, X. (2007) Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Science, 316, 1202-1205.
66. Morris, J.R., Boutell, C., Keppler, M., Densham, R., Weekes, D., Alamshah, A., Butler, L., Galanty, Y., Pangon, L., Kiuchi, T. et al. (2009) The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature, 462, 886-890.
67. Galanty, Y., Belotserkovskaya, R., Coates, J., Polo, S., Miller, K.M. and Jackson, S.P. (2009) Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature, 462, 935-939.
68. Botuyan, M.V., Lee, J., Ward, I.M., Kim, J.-E., Thompson, J.R., Chen, J. and Mer, G. (2006) Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell, 127, 1361-1373.
69. Fradet-Turcotte, A., Canny, M.D., Escribano-Diaz, C., Orthwein, A., Leung, C.C.Y., Huang, H., Landry, M.-C., Kitevski-LeBlanc, J., Noordermeer, S.M., Sicheri, F. et al., (2013) 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark. Nature, 499, 50-54.
70. Feng, L., Fong, K.-W., Wang, J., Wang, W. and Chen, J. (2013) RIF1 Counteracts BRCA1-mediated End Resection during DNA Repair. J. Biol. Chem., 288, 11135-11143.
71. Escribano-Diaz, C., Orthwein, A., Fradet-Turcotte, A., Xing, M., Young, J.T.F., Tkac, J., Cook, M.A., Rosebrock, A.P., Munro, M., Canny, M.D. et al. (2013) A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. Mol. Cell, 49, 872-883.
72. Chapman, J.R., Barral, P., Vannier, J.-B., Borel, V., Steger, M., Tomas-Loba, A., Sartori, A.A., Adams, I.R., Batista, F.D. and Boulton, S.J. (2013) RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection. Mol. Cell, 49, 858-871.
73. Zimmermann, M., Lottersberger, F., Buonomo, S.B., Sfeir, A. and de Lange, T. (2013) 53BP1 regulates DSB repair using Rif1 to control 5' end resection. Science, 339, 700-704.
74. Callen, E., Di Virgilio, M., Kruhlak, M.J., Nieto-Soler, M., Wong, N., Chen, H.-T., Faryabi, R.B., Polato, F., Santos, M., Starnes, L.M. et al., (2013) 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. Cell, 153, 1266-1280.
75. Luo, K., Zhang, H., Wang, L., Yuan, J. and Lou, Z. (2012) Sumoylation of MDC1 is important for proper DNA damage response. EMBO J., 31, 3008-3019.
76. Galanty, Y., Belotserkovskaya, R., Coates, J. and Jackson, S.P. (2012) RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair. Genes Dev., 26, 1179-1195.
77. Yin, Y., Seifert, A., Chua, J.S., Maure, J.-F., Golebiowski, F. and Hay, R.T. (2012) SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage. Genes Dev., 26, 1196-1208.
78. Tang, J., Cho, N.W., Cui, G., Manion, E.M., Shanbhag, N.M., Botuyan, M.V., Mer, G. and Greenberg, R.A. (2013) Acetylation limits 53BP1 association with damaged chromatin to promote homologous recombination. Nat. Struct. Mol. Biol., 20, 317-325.
79. Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G.C.M., Lukas, J. and Jackson, S.P. (2006) ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol., 8, 37-45.
80. Symington, L.S. and Gautier, J. (2011) Double-strand break end resection and repair pathway choice. Annu. Rev. Genet., 45, 247-271.
81. Grabarz, A., Barascu, A., Guirouilh-Barbat, J. and Lopez, B.S. (2012) Initiation of DNA double strand break repair: signaling and single-stranded resection dictate the choice between homologous recombination, non-homologous end-joining and alternative end-joining. Am. J. Cancer Res., 2, 249-268.
82. Chen, L., Nievera, C.J., Lee, A.Y.-L. and Wu, X. (2008) Cell cycle-dependent complex formation of BRCA1. CtIP.MRN is important for DNA double-strand break repair. J. Biol. Chem., 283, 7713-7720.
83. Sartori, A.A., Lukas, C., Coates, J., Mistrik, M., Fu, S., Bartek, J., Baer, R., Lukas, J. and Jackson, S.P. (2007) Human CtIP promotes DNA end resection. Nature, 450, 509-514.
84. Shibata, A., Moiani, D., Arvai, A.S., Perry, J., Harding, S.M., Genois, M.-M., Maity, R., van Rossum-Fikkert, S., Kertokalio, A., Romoli, F. et al. (2014) DNA double-strand break repair pathway choice is directed by distinct MRE11 nuclease activities. Mol. Cell, 53, 7-18.
85. Germani, A., Prabel, A., Mourah, S., Podgorniak, M.-P., Di Carlo, A., Ehrlich, R., Gisselbrecht, S., Varin-Blank, N., Calvo, F. and Bruzzoni-Giovanelli, H. (2003) SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway. Oncogene, 22, 8845-8851.
86. Yu, X. and Chen, J. (2004) DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains. Mol. Cell. Biol., 24, 9478-9486.
87. Huertas, P. and Jackson, S.P. (2009) Human CtIP mediates cell cycle control of DNA end resection and double strand break repair. J. Biol. Chem., 284, 9558-9565.
88. Steger, M., Murina, O., Hühn, D., Ferretti, L.P., Walser, R., Hänggi, K., Lafranchi, L., Neugebauer, C., Paliwal, S., Janscak, P. et al. (2013) Prolyl isomerase PIN1 regulates DNA double-strand break repair by counteracting DNA end resection. Mol. Cell, 50, 333-343.
89. Nimonkar, A.V., Genschel, J., Kinoshita, E., Polaczek, P., Campbell, J.L., Wyman, C., Modrich, P. and Kowalczykowski, S.C. (2011) BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break repair. Genes Dev., 25, 350-362.
90. Tomimatsu, N., Mukherjee, B., Deland, K., Kurimasa, A., Bolderson, E., Khanna, K.K. and Burma, S. (2012) Exo1 plays a major role in DNA end resection in humans and influences double-strand break repair and damage signaling decisions. DNA Repair (Amst.), 11, 441-448.
91. Bolderson, E., Tomimatsu, N., Richard, D.J., Boucher, D., Kumar, R., Pandita, T.K., Burma, S. and Khanna, K.K. (2010) Phosphorylation of Exo1 modulates homologous recombination repair of DNA double-strand breaks. Nucleic Acids Res., 38, 1821-1831.
92. Tomimatsu, N., Mukherjee, B., Hardebeck, M.C., Ilcheva, M., Camacho, C.V., Harris, J.L., Porteus, M., Llorente, B., Khanna, K.K. and Burma, S. (2014) Phosphorylation of EXO1 by CDKs 1 and 2 regulates DNA end resection and repair pathway choice. Nat. Commun., 5, 3561.
93. Chen, X., Paudyal, S.C., Chin, R.-I. and You, Z. (2013) PCNA promotes processive DNA end resection by Exo1. Nucleic Acids Res., 41, 9325-9338.
94. Matsumoto, Y. (2001) Molecular mechanism of PCNA-dependent base excision repair. Prog. Nucleic Acids Res. Mol. Biol., 68, 129-138.
95. Gilljam, K.M., Müller, R., Liabakk, N.B. and Otterlei, M. (2012) Nucleotide excision repair is associated with the replisome and its efficiency depends on a direct interaction between XPA and PCNA. PLoS One, 7, e49199.
96. Umar, A., Buermeyer, A.B., Simon, J.A., Thomas, D.C., Clark, A.B., Liskay, R.M. and Kunkel, T.A. (1996) Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell, 87, 65-73.
97. Kannouche, P.L., Wing, J. and Lehmann, A.R. (2004) Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol. Cell, 14, 491-500.
98. Geng, L., Huntoon, C.J. and Karnitz, L.M. (2010) RAD18-mediated ubiquitination of PCNA activates the Fanconi anemia DNA repair network. J. Cell Biol., 191, 249-257.
99. Sebesta, M., Burkovics, P., Juhasz, S., Zhang, S., Szabo, J.E., Lee, M.Y.W.T., Haracska, L. and Krejci, L. (2013) Role of PCNA and TLS polymerases in D-loop extension during homologous recombination in humans. DNA Repair (Amst.), 12, 691-698.
100. San Filippo, J., Sung, P. and Klein, H. (2008) Mechanism of eukaryotic homologous recombination. Annu. Rev. Biochem., 77, 229-257.
101. Krejci, L., Altmannova, V., Spirek, M. and Zhao, X. (2012) Homologous recombination and its regulation. Nucleic Acids Res., 40, 5795-5818.
102. Holloman, W.K. (2011) Unraveling the mechanism of BRCA2 in homologous recombination. Nat. Struct. Mol. Biol., 18, 748-754.
103. Zhang, F., Fan, Q., Ren, K. and Andreassen, P.R. (2009) PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2. Mol. Cancer Res., 7, 1110-1118.
104. Sy, S.M.H., Huen, M.S.Y. and Chen, J. (2009) PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc. Natl. Acad. Sci. U.S.A., 106, 7155-7160.
105. Li, J., Zou, C., Bai, Y., Wazer, D.E., Band, V. and Gao, Q. (2006) DSS1 is required for the stability of BRCA2. Oncogene, 25, 1186-1194.
106. Liu, J., Doty, T., Gibson, B. and Heyer, W.-D. (2010) Human BRCA2 protein promotes RAD51 filament formation on RPA-covered single-stranded DNA. Nat. Struct. Mol. Biol., 17, 1260-1262.
107. Yuan, J. and Chen, J. (2011) The role of the human SWI5-MEI5 complex in homologous recombination repair. J. Biol. Chem., 286, 9888-9893.
108. Su, G.-C., Chung, C.-I., Liao, C.-Y., Lin, S.-W., Tsai, C.-T., Huang, T., Li, H.-W. and Chi, P. (2013) Enhancement of ADP release from the RAD51 presynaptic filament by the SWI5-SFR1 complex. Nucleic Acids Res., 42, 349-358.
109. Suwaki, N., Klare, K. and Tarsounas, M. (2011) RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis. Semin. Cell Dev. Biol., 22, 898-905.
110. Feng, Z., Scott, S.P., Bussen, W., Sharma, G.G., Guo, G., Pandita, T.K. and Powell, S.N. (2011) Rad52 inactivation is synthetically lethal with BRCA2 deficiency. Proc. Natl. Acad. Sci. U.S.A., 108, 686-691.
111. Mazin, A.V., Mazina, O.M., Bugreev, D.V. and Rossi, M.J. (2010) Rad54, the motor of homologous recombination. DNA Repair (Amst.), 9, 286-302.
112. Modesti, M., Budzowska, M., Baldeyron, C., Demmers, J.A.A., Ghirlando, R. and Kanaar, R. (2007) RAD51AP1 is a structure-specific DNA binding protein that stimulates joint molecule formation during RAD51-mediated homologous recombination. Mol. Cell, 28, 468-481.
113. Wiese, C., Dray, E., Groesser, T., San Filippo, J., Shi, I., Collins, D.W., Tsai, M.-S., Williams, G.J., Rydberg, B., Sung, P. et al. (2007) Promotion of homologous recombination and genomic stability by RAD51AP1 via RAD51 recombinase enhancement. Mol. Cell, 28, 482-490.
114. Richard, D.J., Bolderson, E., Cubeddu, L., Wadsworth, R.I.M., Savage, K., Sharma, G.G., Nicolette, M.L., Tsvetanov, S., McIlwraith, M.J., Pandita, R.K. et al., (2008) Single-stranded DNA-binding protein hSSB1 is critical for genomic stability. Nature, 453, 677-681.
115. Li, Y., Bolderson, E., Kumar, R., Muniandy, P.A., Xue, Y., Richard, D.J., Seidman, M., Pandita, T.K., Khanna, K.K. and Wang, W. (2009) HSSB1 and hSSB2 form similar multiprotein complexes that participate in DNA damage response. J. Biol. Chem., 284, 23525-23531.
116. Moldovan, G.-L., Dejsuphong, D., Petalcorin, M.I.R., Hofmann, K., Takeda, S., Boulton, S.J. and D'Andrea, A.D. (2012) Inhibition of homologous recombination by the PCNA-interacting protein PARI. Mol. Cell, 45, 75-86.
117. O'Connor, K.W., Dejsuphong, D., Park, E., Nicolae, C.M., Kimmelman, A.C., D'Andrea, A.D. and Moldovan, G.-L. (2013) PARI overexpression promotes genomic instability and pancreatic tumorigenesis. Cancer Res., 73, 2529-2539.
118. Hu, Y., Raynard, S., Sehorn, M.G., Lu, X., Bussen, W., Zheng, L., Stark, J.M., Barnes, E.L., Chi, P., Janscak, P. et al. (2007) RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments. Genes Dev., 21, 3073-3084.
119. Fugger, K., Mistrik, M., Danielsen, J.R., Dinant, C., Falck, J., Bartek, J., Lukas, J. and Mailand, N. (2009) Human Fbh1 helicase contributes to genome maintenance via pro- and anti-recombinase activities. J. Cell Biol., 186, 655-663.
120. Bacquin, A., Pouvelle, C., Siaud, N., Perderiset, M., Salomé-Desnoulez, S., Tellier-Lebegue, C., Lopez, B., Charbonnier, J.-B. and Kannouche, P.L. (2013) The helicase FBH1 is tightly regulated by PCNA via CRL4(Cdt2)-mediated proteolysis in human cells. Nucleic Acids Res., 41, 6501-6513.
121. Barber, L.J., Youds, J.L., Ward, J.D., McIlwraith, M.J., O'Neil, N.J., Petalcorin, M.I.R., Martin, J.S., Collis, S.J., Cantor, S.B., Auclair, M. et al. (2008) RTEL1 maintains genomic stability by suppressing homologous recombination. Cell, 135, 261-271.
122. Bachrati, C.Z., Borts, R.H. and Hickson, I.D. (2006) Mobile D-loops are a preferred substrate for the Bloom's syndrome helicase. Nucleic Acids Res., 34, 2269-2279.
123. Chang, J.H., Kim, J.J., Choi, J.M., Lee, J.H. and Cho, Y. (2008) Crystal structure of the Mus81-Eme1 complex. Genes Dev., 22, 1093-1106.
124. Ciccia, A., McDonald, N. and West, S.C. (2008) Structural and functional relationships of the XPF/MUS81 family of proteins. Annu. Rev. Biochem., 77, 259-287.
125. Xu, D., Guo, R., Sobeck, A., Bachrati, C.Z., Yang, J., Enomoto, T., Brown, G.W., Hoatlin, M.E., Hickson, I.D. and Wang, W. (2008) RMI, a new OB-fold complex essential for Bloom syndrome protein to maintain genome stability. Genes Dev., 22, 2843-2855.
126. Rass, U., Compton, S.A., Matos, J., Singleton, M.R., Ip, S.C.Y., Blanco, M.G., Griffith, J.D. and West, S.C. (2010) Mechanism of Holliday junction resolution by the human GEN1 protein. Genes Dev., 24, 1559-1569.
127. Fekairi, S., Scaglione, S., Chahwan, C., Taylor, E.R., Tissier, A., Coulon, S., Dong, M.-Q., Ruse, C., Yates, J.R., Russell, P. et al. (2009) Human SLX4 is a Holliday junction resolvase subunit that binds multiple DNA repair/recombination endonucleases. Cell, 138, 78-89.
128. Bussen, W., Raynard, S., Busygina, V., Singh, A.K. and Sung, P. (2007) Holliday junction processing activity of the BLM-Topo IIIalpha-BLAP75 complex. J. Biol. Chem., 282, 31484-31492.
129. Yang, J., Bachrati, C.Z., Ou, J., Hickson, I.D. and Brown, G.W. (2010) Human topoisomerase IIIalpha is a single-stranded DNA decatenase that is stimulated by BLM and RMI1. J. Biol. Chem., 285, 21426-21436.
130. Wyatt, H.D.M., Sarbajna, S., Matos, J. and West, S.C. (2013) Coordinated Actions of SLX1-SLX4 and MUS81-EME1 for Holliday junction resolution in human cells. Mol. Cell, 52, 234-247.
131. Garner, E., Kim, Y., Lach, F.P., Kottemann, M.C. and Smogorzewska, A. (2013) Human GEN1 and the SLX4-associated nucleases MUS81 and SLX1 are essential for the resolution of replication-induced holliday junctions. Cell Rep., 5, 207-215.
132. Stark, J.M., Pierce, A.J., Oh, J., Pastink, A. and Jasin, M. (2004) Genetic steps of mammalian homologous repair with distinct mutagenic consequences. Mol. Cell. Biol., 24, 9305-9316.
133. Grimme, J.M., Honda, M., Wright, R., Okuno, Y., Rothenberg, E., Mazin, A.V., Ha, T. and Spies, M. (2010) Human Rad52 binds and wraps single-stranded DNA and mediates annealing via two hRad52-ssDNA complexes. Nucleic Acids Res., 38, 2917-2930.
134. Al-Minawi, A.Z., Saleh-Gohari, N. and Helleday, T. (2008) The ERCC1/XPF endonuclease is required for efficient single-strand annealing and gene conversion in mammalian cells. Nucleic Acids Res., 36, 1-9.
135. Göttlich, B., Reichenberger, S., Feldmann, E. and Pfeiffer, P. (1998) Rejoining of DNA double-strand breaks in vitro by single-strand annealing. Eur. J. Biochem., 258, 387-395.
136. Cortizas, E.M., Zahn, A., Hajjar, M.E., Patenaude, A.-M., Di Noia, J.M. and Verdun, R.E. (2013) Alternative End-Joining and Classical Nonhomologous End-Joining Pathways Repair Different Types of Double-Strand Breaks during Class-Switch Recombination. J. Immunol., 191, 5751-5763.
137. Boboila, C., Alt, F.W. and Schwer, B. (2012) Classical and alternative end-joining pathways for repair of lymphocyte-specific and general DNA double-strand breaks. Adv. Immunol., 116, 1-49.
138. Davis, A.J. and Chen, D.J. (2013) DNA double strand break repair via non-homologous end-joining. Transl. Cancer Res., 2, 130-143.
139. Lieber, M.R. (2010) The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu. Rev. Biochem., 79, 181-211.
140. Mladenov, E. and Iliakis, G. (2011) Induction and repair of DNA double strand breaks: the increasing spectrum of non-homologous end joining pathways. Mutat. Res., 711, 61-72.
141. Walker, J.R., Corpina, R.A. and Goldberg, J. (2001) Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature, 412, 607-614.
142. Uematsu, N., Weterings, E., Yano, K.-I., Morotomi-Yano, K., Jakob, B., Taucher-Scholz, G., Mari, P.-O., van Gent, D.C., Chen, B.P.C. and Chen, D.J. (2007) Autophosphorylation of DNA-PKCS regulates its dynamics at DNA double-strand breaks. J. Cell Biol., 177, 219-229.
143. Spagnolo, L., Rivera-Calzada, A., Pearl, L.H. and Llorca, O. (2006) Three-dimensional structure of the human DNA-PKcs/Ku70/Ku80 complex assembled on DNA and its implications for DNA DSB repair. Mol. Cell, 22, 511-519.
144. Soubeyrand, S., Pope, L., De Chasseval, R., Gosselin, D., Dong, F., de Villartay, J.-P. and Haché, R.J.G. (2006) Artemis phosphorylated by DNA-dependent protein kinase associates preferentially with discrete regions of chromatin. J. Mol. Biol., 358, 1200-1211.
145. Nick McElhinny, S.A., Snowden, C.M., McCarville, J. and Ramsden, D.A. (2000) Ku recruits the XRCC4-ligase IV complex to DNA ends. Mol. Cell. Biol., 20, 2996-3003.
146. Mari, P.-O., Florea, B.I., Persengiev, S.P., Verkaik, N.S., Brüggenwirth, H.T., Modesti, M., Giglia-Mari, G., Bezstarosti, K., Demmers, J.A.A., Luider, T.M. et al., (2006) Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc. Natl. Acad. Sci. U.S.A., 103, 18597-18602.
147. Malivert, L., Ropars, V., Nunez, M., Drevet, P., Miron, S., Faure, G., Guerois, R., Mornon, J.-P., Revy, P., Charbonnier, J.-B. et al. (2010) Delineation of the Xrcc4-interacting region in the globular head domain of cernunnos/XLF. J. Biol. Chem., 285, 26475-26483.
148. Bernstein, N.K., Williams, R.S., Rakovszky, M.L., Cui, D., Green, R., Karimi-Busheri, F., Mani, R.S., Galicia, S., Koch, C.A., Cass, C.E. et al. (2005) The molecular architecture of the mammalian DNA repair enzyme, polynucleotide kinase. Mol. Cell, 17, 657-670.
149. Ahel, I., Rass, U., El-Khamisy, S.F., Katyal, S., Clements, P.M., McKinnon, P.J., Caldecott, K.W. and West, S.C. (2006) The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates. Nature, 443, 713-716.
150. Roberts, S.A., Strande, N., Burkhalter, M.D., Strom, C., Havener, J.M., Hasty, P. and Ramsden, D.A. (2010) Ku is a 5'-dRP/AP lyase that excises nucleotide damage near broken ends. Nature, 464, 1214-1217.
151. Li, S., Kanno, S.-I., Watanabe, R., Ogiwara, H., Kohno, T., Watanabe, G., Yasui, A. and Lieber, M.R. (2011) Polynucleotide kinase and aprataxin-like forkhead-associated protein (PALF) acts as both a single-stranded DNA endonuclease and a single-stranded DNA 3' exonuclease and can participate in DNA end joining in a biochemical system. J. Biol. Chem., 286, 36368-36377.
152. Ma, Y., Pannicke, U., Schwarz, K. and Lieber, M.R. (2002) Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell, 108, 781-794.
153. Povirk, L.F., Zhou, T., Zhou, R., Cowan, M.J. and Yannone, S.M. (2007) Processing of 3'-phosphoglycolate-terminated DNA double strand breaks by Artemis nuclease. J. Biol. Chem., 282, 3547-3558.
154. Perry, J.J.P., Yannone, S.M., Holden, L.G., Hitomi, C., Asaithamby, A., Han, S., Cooper, P.K., Chen, D.J. and Tainer, J.A. (2006) WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing. Nat. Struct. Mol. Biol., 13, 414-422.
155. Grundy, G.J., Rulten, S.L., Zeng, Z., Arribas-Bosacoma, R., Iles, N., Manley, K., Oliver, A. and Caldecott, K.W. (2013) APLF promotes the assembly and activity of non-homologous end joining protein complexes. EMBO J., 32, 112-125.
156. Ma, Y., Lu, H., Tippin, B., Goodman, M.F., Shimazaki, N., Koiwai, O., Hsieh, C.-L., Schwarz, K. and Lieber, M.R. (2004) A biochemically defined system for mammalian nonhomologous DNA end joining. Mol. Cell, 16, 701-713.
157. Dueva, R. and Iliakis, G. (2013) Alternative pathways of non-homologous end joining (NHEJ) in genomic instability and cancer. Transl. Cancer Res., 2, 163-177.
158. Truong, L.N., Li, Y., Shi, L.Z., Hwang, P.Y.-H., He, J., Wang, H., Razavian, N., Berns, M.W. and Wu, X. (2013) Microhomology-mediated end joining and homologous recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells. Proc. Nat. Acad. Sci. U.S.A., 110, 7720-7725.
159. Mansour, W.Y., Rhein, T. and Dahm-Daphi, J. (2010) The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies. Nucleic Acids Res., 38, 6065-6077.
160. Wang, M., Wu, W., Wu, W., Rosidi, B., Zhang, L., Wang, H. and Iliakis, G. (2006) PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res., 34, 6170-6182.
161. Cheng, Q., Barboule, N., Frit, P., Gomez, D., Bombarde, O., Couderc, B., Ren, G.S., Salles, B. and Calsou, P. (2011) Ku counteracts mobilization of PARP1 and MRN in chromatin damaged with DNA double-strand breaks. Nucleic Acids Res., 39, 9605-9619.
162. Zhong, Q., Chen, C.-F., Chen, P.-L. and Lee, W.-H. (2002) BRCA1 facilitates microhomology-mediated end joining of DNA double strand breaks. J. Biol. Chem., 277, 28641-28647.
163. Lee-Theilen, M., Matthews, A.J., Kelly, D., Zheng, S. and Chaudhuri, J. (2011) CtIP promotes microhomology-mediated alternative end joining during class-switch recombination. Nat. Struct. Mol. Biol., 18, 75-79.
164. Zhang, Y. and Jasin, M. (2011) An essential role for CtIP in chromosomal translocation formation through an alternative end-joining pathway. Nat. Struct. Mol. Biol., 18, 80-84.
165. Xie, A., Kwok, A. and Scully, R. (2009) Role of mammalian Mre11 in classical and alternative nonhomologous end joining. Nat. Struct. Mol. Biol., 16, 814-818.
166. Rass, E., Grabarz, A., Plo, I., Gautier, J., Bertrand, P. and Lopez, B.S. (2009) Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells. Nat. Struct. Mol. Biol., 16, 819-824.
167. Bothmer, A., Robbiani, D.F., Feldhahn, N., Gazumyan, A., Nussenzweig, A. and Nussenzweig, M.C. (2010) 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination. J. Exp. Med., 207, 855-865.
168. Bothmer, A., Robbiani, D.F., Di Virgilio, M., Bunting, S.F., Klein, I.A., Feldhahn, N., Barlow, J., Chen, H.-T., Bosque, D., Callen, E. et al. (2011) Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1. Mol. Cell, 42, 319-329.
169. Wang, H., Rosidi, B., Perrault, R., Wang, M., Zhang, L., Windhofer, F. and Iliakis, G. (2005) DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res., 65, 4020-4030.
170. Liang, L., Deng, L., Nguyen, S.C., Zhao, X., Maulion, C.D., Shao, C. and Tischfield, J.A. (2008) Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks. Nucleic Acids Res., 36, 3297-3310.
171. Della-Maria, J., Zhou, Y., Tsai, M.-S., Kuhnlein, J., Carney, J.P., Paull, T.T. and Tomkinson, A.E. (2011) Human Mre11/human Rad50/Nbs1 and DNA ligase IIIalpha/XRCC1 protein complexes act together in an alternative nonhomologous end joining pathway. J. Biol. Chem., 286, 33845-33853.
172. Paul, K., Wang, M., Mladenov, E., Bencsik-Theilen, A., Bednar, T., Wu, W., Arakawa, H. and Iliakis, G. (2013) DNA ligases I and III cooperate in alternative non-homologous end-joining in vertebrates. PLoS One, 8, e59505.
173. Zeman, M.K. and Cimprich, K.A. (2014) Causes and consequences of replication stress. Nat. Cell Biol., 16, 2-9.
174. Branzei, D. and Foiani, M. (2010) Maintaining genome stability at the replication fork. Nat Rev Mol Cell Biol, 11, 208-219.
175. Hanada, K., Budzowska, M., Davies, S.L., van Drunen, E., Onizawa, H., Beverloo, H.B., Maas, A., Essers, J., Hickson, I.D. and Kanaar, R. (2007) The structure-specific endonuclease Mus81 contributes to replication restart by generating double-strand DNA breaks. Nat. Struct. Mol. Biol., 14, 1096-1104.
176. Chen, S. and Parmigiani, G. (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J. Clin. Oncol., 25, 1329-1333.
177. Howlader, N., Noone, A.M., Krapcho, M., Garshell, J., Neyman, N., Altekruse, S.F., Kosary, C.L., Yu, M., Ruhl, J., Tatalovich, Z. et al., SEER Cancer Statistics Review, 1975-2010. seer.cancer.gov.
178. Cerbinskaite, A., Mukhopadhyay, A., Plummer, E.R., Curtin, N.J. and Edmondson, R.J. (2012) Defective homologous recombination in human cancers. Cancer Treat. Rev., 38, 89-100.
179. Khanna, K.K. and Chenevix-Trench, G. (2004) ATM and genome maintenance: defining its role in breast cancer susceptibility. J. Mammary Gland Biol. Neoplasia, 9, 247-262.
180. Swift, M., Reitnauer, P.J., Morrell, D. and Chase, C.L. (1987) Breast and other cancers in families with ataxia-telangiectasia. N. Engl. J. Med., 316, 1289-1294.
181. Jones, S., Zhang, X., Parsons, D.W., Lin, J.C.-H., Leary, R.J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A. et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science, 321, 1801-1806.
182. Koboldt, D.C., Fulton, R.S., McLellan, M.D., Schmidt, H., Kalicki-Veizer, J., McMichael, J.F., Fulton, L.L., Dooling, D.J., Ding, L., Mardis, E.R. et al. (2012) Comprehensive molecular portraits of human breast tumours. Nature, 490, 61-70.
183. Curtis, C., Shah, S.P., Chin, S.-F., Turashvili, G., Rueda, O.M., Dunning, M.J., Speed, D., Lynch, A.G., Samarajiwa, S., Yuan, Y. et al. (2012) The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups. Nature, 486, 346-352.
184. Shah, S.P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Ding, J., Tse, K., Haffari, G. et al. (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature, 486, 395-399.
185. Stephens, P.J., Tarpey, P.S., Davies, H., Van Loo, P., Greenman, C., Wedge, D.C., Nik-Zainal, S., Martin, S., Varela, I., Bignell, G.R. et al. (2012) The landscape of cancer genes and mutational processes in breast cancer. Nature, 486, 400-404.
186. Banerji, S., Cibulskis, K., Rangel-Escareno, C., Brown, K.K., Carter, S.L., Frederick, A.M., Lawrence, M.S., Sivachenko, A.Y., Sougnez, C., Zou, L. et al. (2012) Sequence analysis of mutations and translocations across breast cancer subtypes. Nature, 486, 405-409.
187. Futreal, P.A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N. and Stratton, M.R. (2004) A census of human cancer genes. Nat. Rev. Cancer, 4, 177-183.
188. Stephens, P.J., Greenman, C.D., Fu, B., Yang, F., Bignell, G.R., Mudie, L.J., Pleasance, E.D., Lau, K.W., Beare, D., Stebbings, L.A. et al. (2011) Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell, 144, 27-40.
189. Yang, L., Luquette, L.J., Gehlenborg, N., Xi, R., Haseley, P.S., Hsieh, C.-H., Zhang, C., Ren, X., Protopopov, A., Chin, L. et al. (2013) Diverse mechanisms of somatic structural variations in human cancer genomes. Cell, 153, 919-929.
190. Zhang, C.-Z., Leibowitz, M.L. and Pellman, D. (2013) Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements. Genes Dev., 27, 2513-2530.
191. Iwakawa, R., Takenaka, M., Kohno, T., Shimada, Y., Totoki, Y., Shibata, T., Tsuta, K., Nishikawa, R., Noguchi, M., Sato-Otsubo, A. et al. (2013) Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer. Genes Chromosomes Cancer, 52, 802-816.
192. Malhotra, A., Lindberg, M., Faust, G.G., Leibowitz, M.L., Clark, R.A., Layer, R.M., Quinlan, A.R. and Hall, I.M. (2013) Breakpoint profiling of 64 cancer genomes reveals numerous complex rearrangements spawned by homology-independent mechanisms. Genome Res., 23, 762-776.
193. Rausch, T., Jones, D.T.W., Zapatka, M., Stütz, A.M., Zichner, T., Weischenfeldt, J., Jäger, N., Remke, M., Shih, D., Northcott, P.A. et al. (2012) Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell, 148, 59-71.
194. Kloosterman, W.P., Guryev, V., van Roosmalen, M., Duran, K.J., de Bruijn, E., Bakker, S.C.M., Letteboer, T., van Nesselrooij, B., Hochstenbach, R., Poot, M. et al. (2011) Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline. Hum. Mol. Genet., 20, 1916-1924.
195. Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Aparicio, S.A.J.R., Behjati, S., Biankin, A.V., Bignell, G.R., Bolli, N., Borg, A., Børresen-Dale, A.-L. et al. (2013) Signatures of mutational processes in human cancer. Nature, 500, 415-421.
196. Ciriello, G., Miller, M.L., Aksoy, B.A., Senbabaoglu, Y., Schultz, N. and Sander, C. (2013) Emerging landscape of oncogenic signatures across human cancers. Nat. Genet., 45, 1127-1133.
197. Nik-Zainal, S., Alexandrov, L.B., Wedge, D.C., Van Loo, P., Greenman, C.D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L.A. et al. (2012) Mutational processes molding the genomes of 21 breast cancers. Cell, 149, 979-993.
198. Nik-Zainal, S., Van Loo, P., Wedge, D.C., Alexandrov, L.B., Greenman, C.D., Lau, K.W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M. et al., (2012) The life history of 21 breast cancers. Cell, 149, 994-1007.
199. Koito, A. and Ikeda, T. (2013) Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases. Front. Microbiol., 4, 28.
200. Burns, M.B., Lackey, L., Carpenter, M.A., Rathore, A., Land, A.M., Leonard, B., Refsland, E.W., Kotandeniya, D., Tretyakova, N., Nikas, J.B. et al. (2013) APOBEC3B is an enzymatic source of mutation in breast cancer. Nature, 494, 366-370.
201. Al-Ejeh, F., Kumar, R., Wiegmans, A., Lakhani, S.R., Brown, M.P. and Khanna, K.K. (2010) Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes. Oncogene, 29, 6085-6098.
202. Evers, B., Helleday, T. and Jonkers, J. (2010) Targeting homologous recombination repair defects in cancer. Trends Pharmacol. Sci., 31, 372-380.
203. Bolderson, E., Richard, D.J., Zhou, B.-B.S. and Khanna, K.K. (2009) Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair. Clin. Cancer Res., 15, 6314-6320.
204. Cheung-Ong, K., Giaever, G. and Nislow, C. (2013) DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology. Chem. Biol., 20, 648-659.
205. Boone, C., Bussey, H. and Andrews, B.J. (2007) Exploring genetic interactions and networks with yeast. Nat. Rev. Genet., 8, 437-449.
206. Nijman, S.M.B. (2011) Synthetic lethality: general principles, utility and detection using genetic screens in human cells. FEBS Lett., 585, 1-6.
207. O'Neil, N.J., van Pel, D.M. and Hieter, P. (2013) Synthetic lethality and cancer: cohesin and PARP at the replication fork. Trends Genet., 29, 290-297.
208. Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
209. Sandmann, T. and Boutros, M. (2012) Screens, maps & networks: from genome sequences to personalized medicine. Curr. Opin. Genet. Dev., 22, 36-44.
210. Farmer, H., McCabe, N., Lord, C.J., Tutt, A.N.J., Johnson, D.A., Richardson, T.B., Santarosa, M., Dillon, K.J., Hickson, I., Knights, C. et al. (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature, 434, 917-921.
211. Bryant, H.E., Schultz, N., Thomas, H.D., Parker, K.M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N.J. and Helleday, T. (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature, 434, 913-917.
212. Fong, P.C., Boss, D.S., Yap, T.A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M.J. et al. (2009) Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N. Engl. J. Med., 361, 123-134.
213. Tsutsumi, M., Masutani, M., Nozaki, T., Kusuoka, O., Tsujiuchi, T., Nakagama, H., Suzuki, H., Konishi, Y. and Sugimura, T. (2001) Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout mice to nitrosamine carcinogenicity. Carcinogenesis, 22, 1-3.
214. Shall, S. and de Murcia, G. (2000) Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat. Res., 460, 1-15.
215. Gottipati, P., Vischioni, B., Schultz, N., Solomons, J., Bryant, H.E., Djureinovic, T., Issaeva, N., Sleeth, K., Sharma, R.A. and Helleday, T. (2010) Poly(ADP-ribose) polymerase is hyperactivated in homologous recombination- defective cells. Cancer Res., 70, 5389-5398.
216. Patel, A.G., Sarkaria, J.N. and Kaufmann, S.H. (2011) Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells. Proc. Natl. Acad. Sci. U.S.A., 108, 3406-3411.
217. Helleday, T. (2011) The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings. Mol. Oncol., 5, 387-393.
218. Yang, Y.-G., Cortes, U., Patnaik, S., Jasin, M. and Wang, Z.-Q. (2004) Ablation of PARP-1 does not interfere with the repair of DNA double-strand breaks, but compromises the reactivation of stalled replication forks. Oncogene, 23, 3872-3882.
219. Ying, S., Hamdy, F.C. and Helleday, T. (2012) Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1. Cancer Res., 72, 2814-2821.
220. Bryant, H.E., Petermann, E., Schultz, N., Jemth, A.-S., Loseva, O., Issaeva, N., Johansson, F., Fernandez, S., McGlynn, P. and Helleday, T. (2009) PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination. EMBO J., 28, 2601-2615.
221. Ström, C. and Helleday, T. (2012) Strategies for the use of Poly(adenosine diphosphate ribose) Polymerase (PARP) inhibitors in Cancer therapy. Biomolecules, 2, 635-649.
222. Curtin, N.J. (2005) PARP inhibitors for cancer therapy. Expert Rev. Mol. Med., 7, 1-20.
223. Murai, J., Huang, S.-Y.N., Das, B.B., Renaud, A., Zhang, Y., Doroshow, J.H., Ji, J., Takeda, S. and Pommier, Y. (2012) Trapping of PARP1 and PARP2 by clinical PARP inhibitors. Cancer Res., 72, 5588-5599.
224. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V.F., Kolettas, E., Niforou, K., Zoumpourlis, V.C. et al. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature, 444, 633-637.
225. de Murcia, J.M., Niedergang, C., Trucco, C., Ricoul, M., Dutrillaux, B., Mark, M., Oliver, F.J., Masson, M., Dierich, A., LeMeur, M. et al. (1997) Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc. Natl. Acad. Sci. U.S.A., 94, 7303-7307.
226. Wang, Z.Q., Stingl, L., Morrison, C., Jantsch, M., Los, M., Schulze-Osthoff, K. and Wagner, E.F. (1997) PARP is important for genomic stability but dispensable in apoptosis. Genes Dev., 11, 2347-2358.
227. McCabe, N., Turner, N.C., Lord, C.J., Kluzek, K., Bialkowska, A., Swift, S., Giavara, S., O'Connor, M.J., Tutt, A.N., Zdzienicka, M.Z. et al. (2006) Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res., 66, 8109-8115.
228. Drost, R., Bouwman, P., Rottenberg, S., Boon, U., Schut, E., Klarenbeek, S., Klijn, C., van der Heijden, I., van der Gulden, H., Wientjens, E. et al. (2011) BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance. Cancer Cell, 20, 797-809.
229. Drost, R. and Jonkers, J. (2013) Opportunities and hurdles in the treatment of BRCA1-related breast cancer. Oncogene, 10, 1-11.
230. Swisher, E.M., Sakai, W., Karlan, B.Y., Wurz, K., Urban, N. and Taniguchi, T. (2008) Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance. Cancer Res., 68, 2581-2586.
231. Norquist, B., Wurz, K.A., Pennil, C.C., Garcia, R., Gross, J., Sakai, W., Karlan, B.Y., Taniguchi, T. and Swisher, E.M. (2011) Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas. J. Clin. Oncol., 29, 3008-3015.
232. Bouwman, P. and Jonkers, J. (2012) The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance. Nat. Rev. Cancer, 12, 587-598.
233. Edwards, S.L., Brough, R., Lord, C.J., Natrajan, R., Vatcheva, R., Levine, D.A., Boyd, J., Reis-Filho, J.S. and Ashworth, A. (2008) Resistance to therapy caused by intragenic deletion in BRCA2. Nature, 451, 1111-1115.
234. Sakai, W., Swisher, E.M., Karlan, B.Y., Agarwal, M.K., Higgins, J., Friedman, C., Villegas, E., Jacquemont, C., Farrugia, D.J., Couch, F.J. et al. (2008) Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature, 451, 1116-1120.
235. Jaspers, J.E., Kersbergen, A., Boon, U., Sol, W., van Deemter, L., Zander, S.A., Drost, R., Wientjens, E., Ji, J., Aly, A. et al., (2013) Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors. Cancer Discov., 3, 68-81.
236. Johnson, N., Johnson, S.F., Yao, W., Li, Y.-C., Choi, Y.-E., Bernhardy, A.J., Wang, Y., Capelletti, M., Sarosiek, K.A., Moreau, L.A. et al. (2013) Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance. Proc. Natl. Acad. Sci. U.S.A., 110, 17041-17046.
237. Pace, P., Mosedale, G., Hodskinson, M.R., Rosado, I.V., Sivasubramaniam, M. and Patel, K.J. (2010) Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway. Science, 329, 219-223.
238. Adamo, A., Collis, S.J., Adelman, C.A., Silva, N., Horejsí, Z., Ward, J.D., Martinez-Perez, E., Boulton, S.J. and La Volpe, A. (2010) Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia. Mol. Cell, 39, 25-35.
239. Barabási, A.-L., Gulbahce, N. and Loscalzo, J. (2011) Network medicine: a network-based approach to human disease. Nat. Rev. Genet., 12, 56-68.
240. Michor, F., Hughes, T.P., Iwasa, Y., Branford, S., Shah, N.P., Sawyers, C.L. and Nowak, M.A. (2005) Dynamics of chronic myeloid leukaemia. Nature, 435, 1267-1270.
241. Srihari, S. and Ragan, M.A. (2013) Systematic tracking of dysregulated modules identifies novel genes in cancer. Bioinformatics, 29(12)1553-1561.
242. Hindorff, L.A., Sethupathy, P., Junkins, H.A., Ramos, E.M., Mehta, J.P., Collins, F.S. and Manolio, T.A. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U.S.A., 106, 9362-9367.
243. Li, F.P., Fraumeni, J.F., Mulvihill, J.J., Blattner, W.A., Dreyfus, M.G., Tucker, M.A. and Miller, R.W. (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res., 48, 5358-5362.
244. Masciari, S., Dillon, D.A., Rath, M., Robson, M., Weitzel, J.N., Balmana, J., Gruber, S.B., Ford, J.M., Euhus, D., Lebensohn, A. et al. (2012) Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res. Treat., 133, 1125-1130.
245. Lee, J., Kim, D.-H., Lee, S., Yang, Q.-H., Lee, D.K., Lee, S.-K., Roeder, R.G. and Lee, J.W. (2009) A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4. Proc. Natl. Acad. Sci. U.S.A., 106, 8513-8518.
246. Bennetzen, M.V., Larsen, D.H., Dinant, C., Watanabe, S., Bartek, J., Lukas, J. and Andersen, J.S. (2013) Acetylation dynamics of human nuclear proteins during the ionizing radiation-induced DNA damage response. Cell Cycle, 12, 1688-1695.
247. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C. and Micklem, G. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature, 378, 789-792.
248. Liaw, D., Marsh, D.J., Li, J., Dahia, P.L., Wang, S.I., Zheng, Z., Bose, S., Call, K.M., Tsou, H.C., Peacocke, M. et al. (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16, 64-67.
249. Tavtigian, S.V., Oefner, P.J., Babikyan, D., Hartmann, A., Healey, S., Le Calvez-Kelm, F., Lesueur, F., Byrnes, G.B., Chuang, S.-C., Forey, N. et al. (2009) Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am. J. Hum. Genet., 85, 427-446.
250. Vo, Q.N., Kim, W.-J., Cvitanovic, L., Boudreau, D.A., Ginzinger, D.G. and Brown, K.D. (2004) The ATM gene is a target for epigenetic silencing in locally advanced breast cancer. Oncogene, 23, 9432-9437.
251. Brennan, K., García-Closas, M., Orr, N., Fletcher, O., Jones, M., Ashworth, A., Swerdlow, A., Thorne, H. and kConFab InvestigatorskConFab Investigators and Riboli, E. et al., (2012) Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. Cancer Res., 72, 2304-2313.
252. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L.M. and Ding, W. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
253. Esteller, M., Silva, J.M., Dominguez, G., Bonilla, F., Matias-Guiu, X., Lerma, E., Bussaglia, E., Prat, J., Harkes, I.C., Repasky, E.A. et al. (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst., 92, 564-569.
254. Puc, J., Keniry, M., Li, H.S., Pandita, T.K., Choudhury, A.D., Memeo, L., Mansukhani, M., Murty, V.V.V.S., Gaciong, Z., Meek, S.E.M. et al. (2005) Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell, 7, 193-204.
255. Marees, T., Moll, A.C., Imhof, S.M., de Boer, M.R., Ringens, P.J. and van Leeuwen, F.E. (2008) Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J. Natl. Cancer Inst., 100, 1771-1779.
256. Seal, S., Thompson, D., Renwick, A., Elliott, A., Kelly, P., Barfoot, R., Chagtai, T., Jayatilake, H., Ahmed, M., Spanova, K. et al. (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat. Genet., 38, 1239-1241.
257. Meijers-Heijboer, H., van den Ouweland, A., Klijn, J., Wasielewski, M., de Snoo, A., Oldenburg, R., Hollestelle, A., Houben, M., Crepin, E., van Veghel-Plandsoen, M. et al., (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet., 31, 55-59.
258. Wiesner, T., Fried, I., Ulz, P., Stacher, E., Popper, H., Murali, R., Kutzner, H., Lax, S., Smolle-Jüttner, F., Geigl, J.B. et al. (2012) Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations. J. Clin. Oncol., 30, e337-e340.
259. Jirawatnotai, S., Hu, Y., Michowski, W., Elias, J.E., Becks, L., Bienvenu, F., Zagozdzon, A., Goswami, T., Wang, Y.E., Clark, A.B. et al. (2011) A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature, 474, 230-234.
260. French, J.D., Ghoussaini, M., Edwards, S.L., Meyer, K.B., Michailidou, K., Ahmed, S., Khan, S., Maranian, M.J., O'Reilly, M., Hillman, K.M. et al. (2013) Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am. J. Hum. Genet., 92, 489-503.
261. Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., Chagtai, T. et al. (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet., 39, 165-167.